Company Overview and News

 
Colorado counties sue Exxon, Suncor over climate change

7h cnbc
Boulder and San Miguel counties in Colorado are suing ExxonMobil and Suncor Energy for their effects on the environment and their negative contributions to climate change.
Upvote Downvote

 
If You’re Thinking of Retiring in San Miguel de Allende - WSJ

2018-04-19 wsj
Lots of people want to retire to a beach. My husband, George, and I gave up the Jersey Shore for the Mexican interior 12 years ago, and we haven’t looked back.
Upvote Downvote

 
Don’t make me, Uber

2018-04-19 bworldonline
It was just supposed to be a business deal. And in the old days, that would have meant a simple handshake and a smile. Not anymore.
Upvote Downvote

 
PBA Commissioner’s Cup kicks off at the Big Dome

2018-04-19 bworldonline
THE Philippine Basketball Association (PBA) returns this weekend with the Commissioner’s Cup kicking off with a double-header at the Smart Araneta Coliseum.
Upvote Downvote

 
Latest legal fight accusing oil companies of climate change launched in Colorado

2018-04-17 reuters
NEW YORK, April 17 (Thomson Reuters Foundation) - Three Colorado communities filed a lawsuit against oil companies on Tuesday, launching the latest legal battle seeking damages for what they claim are the costs of adapting to climate change.
Upvote Downvote

 
A biased Supreme Court, threat to our fragile democracy

2018-04-17 bworldonline
Unless The Supreme Court, sitting as the Presidential Electoral Tribunal (PET) reverses itself on its position that a resolution issued in Year 2010 stipulating a minimum of 50% shading of the ballot ovals is required for validation of the ballot, its bias for the rich will become even more obvious. The Comelec had recognized a 25% shading threshold in an en banc resolution.
Upvote Downvote

3
San Miguel Continuing To Fire On All Cylinders

2018-04-16 seekingalpha
San Miguel (OTCPK:SMGBY) produced full year results which were very well received by the market. Growth across all its sectors looks set to continue in 2018. It remains a good play on the growing Philippines economy as a whole. In addition there is the possibility of new developments which would cause its stock price to rise faster than the current organic growth and good valuation would imply.
Upvote Downvote

1
Up for auction–furniture from famous Legarda house in San Miguel, Manila

2018-04-15 lifestyle.inquirer.net
Excellent furniture made during the first quarter of the 20th century and which graced the famous house in San Miguel, Manila, of Alejandro Roces Legarda will be auctioned off León Gallery’s 7th online auction on April 27-28, starting at 2 p.m.
Upvote Downvote

1
Understanding the two proposals to rehabilitate NAIA

2018-04-15 bworldonline
Consider this: The country’s principal gateway processed 42 million passengers last year, 11 million more than it was built for. In the next five years, air traffic is seen to reach a whopping 74 million passengers on the back of our strong economy.
Upvote Downvote

 
Boracay may reopen in 4 months but with limited tourists: Teo

2018-04-11 bworldonline
The Philippines is looking to shorten the closure period for its most popular holiday hotspot Boracay to four months from six, but the number of visitors allowed when it reopens will be slashed, the tourism secretary said on Wednesday.
Upvote Downvote

 
Pure Foods share sale seen to become bigger

2018-04-10 business.inquirer.net
What is set to become the largest share sale in Philippine history may become even bigger after San Miguel Corp.’s chief said he could offer as much as a third of the conglomerate’s soon-to-be-consolidated food and beverage businesses to the investing public.
Upvote Downvote

 
San Miguel seeks up to $3.6 billion in share sale at merged unit

2018-04-10 bworldonline
SAN MIGUEL Corp., the Philippines’ largest company, expects to raise as much as $3.6-billion selling shares of its merged food and drinks unit in the fourth quarter in what could be the country’s biggest share sale on record.
Upvote Downvote

 
San Miguel Seeks Up to $3.6 Billion in Share Sale at Merged Unit - Bloomberg

2018-04-10 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Finals loss just a bump in the journey — Magnolia

2018-04-09 bworldonline
AS CLICHÉ as it sounds, the Magnolia Hotshots Pambansang Manok are viewing their recent campaign in the PBA Philippine Cup as more of the journey than the destination; that the experience they had in it should only serve to make them stronger as they continue to make their trek back to league elite status.
Upvote Downvote

 
Success born from special relationship

2018-04-08 bworldonline
THE San Miguel Beermen further lionized themselves as a franchise in the Philippine Basketball Association (PBA) after making history on Friday by winning their fourth straight PBA Philippine Cup title.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...